The two day event will bring together  pharmacovigilance personnel from key pharmaceutical companies and will address the challenges in monitoring and maintaining drug safety strategies, will discuss how to apply new technologies and strategic approaches to effectively manage drug safety and will discover key developments in the handling, analysis and reporting of adverse events during trials and understand the regulators requirements with the aim of speeding drugs to market whilst mitigating the risk of recall.